Cargando…

ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma

Recent studies have indicated that low circulating adiponectin concentrations are associated with a higher risk of several cancers, including renal cell carcinoma. In this case–control study, we examined the frequency of single nucleotide polymorphisms (rs182052G>A, rs266729C>G, and rs3774262G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Guiming, Gu, Chengyuan, Zhu, Yao, Luo, Lei, Dong, Dahai, Wan, Fangning, Zhang, Hailiang, Shi, Guohai, Sun, Lijiang, Ye, Dingwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2015
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471788/ https://www.ncbi.nlm.nih.gov/pubmed/25827778 http://dx.doi.org/10.1111/cas.12664

Ejemplares similares

Obesity, osteoarthritis and genetic risk: The rs182052 polymorphism in the ADIPOQ gene is potentially associated with risk of knee osteoarthritis
por: Jiang, L., et al.
Publicado: (2018)

Polymorphisms FTO rs9939609, PPARG rs1801282 and ADIPOQ rs4632532 and rs182052 but not lifestyle are associated with obesity related-traits in Mexican children
por: Muñoz-Yáñez, C, et al.
Publicado: (2016)

A single nucleotide polymorphism in ADIPOQ predicts biochemical recurrence after radical prostatectomy in localized prostate cancer
por: Gu, Chengyuan, et al.
Publicado: (2015)

Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma
por: Wu, Junlong, et al.
Publicado: (2019)

Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients
por: Wan, Fangning, et al.
Publicado: (2015)

Serum Adiponectin Level May be an Independent Predictor of Clear Cell Renal Cell Carcinoma
por: Wang, Hongkai, et al.
Publicado: (2016)

Clinical outcome of advanced and metastatic renal cell carcinoma treated with targeted therapy: is there a difference between young and old patients?
por: Zhang, Guiming, et al.
Publicado: (2014)

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico
por: Jin, Shengming, et al.
Publicado: (2018)

The association between adiponectin gene rs182052 polymorphism and cancer risk: a meta-analysis
por: Wu, Li-Fang, et al.
Publicado: (2020)

Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
por: Gu, Weijie, et al.
Publicado: (2015)

m(6)A Regulator-Mediated Methylation Modification Model Predicts Prognosis, Tumor Microenvironment Characterizations and Response to Immunotherapies of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma
por: Xu, Wenhao, et al.
Publicado: (2021)

Prognostic significance of the dynamic changes of systemic inflammatory response in metastatic renal cell carcinoma
por: Wang, Beihe, et al.
Publicado: (2019)

B7-H3 is a new cancer-specific endothelial marker in clear cell renal cell carcinoma
por: Qin, Xiaojian, et al.
Publicado: (2013)

Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma
por: Wang, Yue, et al.
Publicado: (2018)

Decreased TCL6 expression is associated with poor prognosis in patients with clear cell renal cell carcinoma
por: Su, Hengchuan, et al.
Publicado: (2016)

Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma
por: Fangning, Wan, et al.
Publicado: (2017)

High expression of F2RL3 correlates with aggressive features and poor survival in clear cell renal cell carcinoma
por: Cao, Dalong, et al.
Publicado: (2018)

ADIPOQ rs2241766 Gene Polymorphism and Predisposition to Diabetic Kidney Disease
por: Han, Qiuxia, et al.
Publicado: (2020)

Development and validation of a mitochondrial metabolism‐associated nomogram for prediction of prognosis in clear cell renal cell carcinoma
por: Zeng, Bohan, et al.
Publicado: (2020)

The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2017)

Association of Adiponectin Gene (ADIPOQ) rs2241766 Polymorphism with Obesity in Adults: A Meta-Analysis
por: Wu, Jingjing, et al.
Publicado: (2014)

Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients
por: Wu, Junlong, et al.
Publicado: (2017)

Author Correction: The Oncogenic Role of COL23A1 in Clear Cell Renal Cell Carcinoma
por: Xu, Fujiang, et al.
Publicado: (2018)

Prognostic Immunophenotyping Clusters of Clear Cell Renal Cell Carcinoma Defined by the Unique Tumor Immune Microenvironment
por: Xu, Wenhao, et al.
Publicado: (2021)

A 5-lncRNA Signature Associated with Smoking Predicts the Overall Survival of Patients with Muscle-Invasive Bladder Cancer
por: Sheng, Haoyue, et al.
Publicado: (2021)

A novel amino acid metabolism-related gene risk signature for predicting prognosis in clear cell renal cell carcinoma
por: Su, Jiaqi, et al.
Publicado: (2022)

Oligometastatic state predicts a favorable outcome for renal cell carcinoma patients with bone metastasis under the treatment of sunitinib
por: Lu, Xiaolin, et al.
Publicado: (2016)

Diagnosis of adults Xp11.2 translocation renal cell carcinoma by immunohistochemistry and FISH assays: clinicopathological data from ethnic Chinese population
por: Qu, Yuanyuan, et al.
Publicado: (2016)

Deciphering the role of miR-187-3p/LRFN1 axis in modulating progression, aerobic glycolysis and immune microenvironment of clear cell renal cell carcinoma
por: Xu, Wenhao, et al.
Publicado: (2022)

Associations between three common single nucleotide polymorphisms (rs266729, rs2241766, and rs1501299) of ADIPOQ and cardiovascular disease: a meta-analysis
por: Kanu, Joseph Sam, et al.
Publicado: (2018)

Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer
por: Wan, Fangning, et al.
Publicado: (2014)

Early skeletal muscle loss during target therapy is a prognostic biomarker in metastatic renal cell carcinoma patients
por: Gu, Weijie, et al.
Publicado: (2017)

Retrograde radical cystectomy and consequent peritoneal cavity reconstruction benefits localized male bladder cancer: results from a cohort study
por: Qin, Xiaojian, et al.
Publicado: (2015)

Conditional Survival in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab
por: Shao, Ning, et al.
Publicado: (2019)

Association of Adiponectin and rs1501299 of the ADIPOQ Gene with Prediabetes in Jordan
por: Alfaqih, Mahmoud A., et al.
Publicado: (2018)

Impact of Estrogen on the Relationship Between Obesity and Renal Cell Carcinoma Risk in Women
por: Sun, Lijiang, et al.
Publicado: (2018)

Prognostic Value of Components of Body Composition in Patients Treated with Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Case Series
por: Gu, Weijie, et al.
Publicado: (2015)

Age-Dependent Association between Sex and Renal Cell Carcinoma Mortality: a Population-Based Analysis
por: Qu, Yuanyuan, et al.
Publicado: (2015)

Application of Internet-based multidisciplinary management in patients with genitourinary cancers in China: A brief introduction to a new model of healthcare service for cancer survivors during COVID-19 pandemic
por: Zhu, Yu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5seu1mgbmqe5gai13c8d9np48f